Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof
US10184010B2 · kind B2 · utility
4Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2014 |
| Grant date | Jan 22, 2019 |
| Priority date | — |
| Expiry date | Nov 16, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a novel dual-targeting protein comprising: a protein that binds specifically to delta-like ligand 4 (DLL4); and an antibody that binds specifically to vascular endothelial cell growth factor (VEGF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.